Effect of different luteinizing hormone levels on corpus luteum function during controlled ovraian stimulation with GnRH-antagonist protocol

Effect of different luteinizing hormone levels on corpus luteum function during controlled ovraian stimulation with GnRH-antagonist protocol in normal ovarian reverse patients: a prospective cohort study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025680

Enrollment

Unknown

Registered

2019-09-05

Start date

2019-10-15

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

LH max =10 group.:GnRH-antagonist regimen

Eligibility

Sex/Gender

Female

Age

22 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 22-38 years; 2. Basal FSH <= 10 IU/L; 3. AFC=6; 4. BMI20-28kg/m2; 5. COS with GnRH antagonist protocol; 6. The subjects must be volunteers and sign informed consents in person or by the legal representative.

Exclusion criteria

Exclusion criteria: 1. Ultrasound or hysteroscopy indicated intrauterine or endometrial lesion, including uterine malformation, endometrial polyp, hyperplasia, intrauterine adhesion, etc; 2. Endometriosis, adenomyosis; 3. Medical comorbidities like diabetes mellitus. 4. DOR patients; 5. Hypogonadotropic amenorrhea patients; 6. E2 > 4000pg/ml; 7. P > 1.5ng/ml.

Design outcomes

Primary

Measure	Time frame
LHR;	—

Secondary

Measure	Time frame
17-OH-P;	—

Countries

China

Contacts

Public ContactYuan Li

Beijing Chaoyang Hospital affiliated to Capital Medical University

sdliyuan@126.com+86 010-85231423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026